Novo Nordisk: PharmaVitae Profile
Novo Nordisk: PharmaVitae Profile
Published Date: October 2006
Published By: Datamonitor
Page Count: 108
Order Code: R313-16988
Price: $5700 Online Download
$11400 Global Site License
Introduction
This analysis examines the historical and forecast performance for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Reasons to Purchase
Benchmark Novo Nordisk's performance against key rivals in the ethical pharmaceutical sector
Analyze the driving forces behind Novo's growth rate to 2011, which is expected to be one of the highest in its Mid Pharma peer set
See how the company will be insulated from the threat of biogeneric incursion by its range of delivery devices and tailored insulin products
Votes:23
Comments: 0